Esomeprazole PCD Pharma Franchise Company

Cafoli Lifecare offers a comprehensive Esomeprazole PCD pharma franchise built on 12 formulations across capsules, tablets, sachets and injection, all made at WHO-GMP certified facilities. This depth gives franchise partners a high-volume gastro line suited to every prescriber and dosing need.

What is Esomeprazole?

Esomeprazole is a proton-pump inhibitor (PPI) — the S-isomer of omeprazole — that suppresses gastric acid secretion by irreversibly blocking the H+/K+-ATPase enzyme in the stomach's parietal cells. It is used to treat acid-related disorders and to protect the stomach during long-term NSAID use. Read its profile on MedlinePlus.

Therapeutic Applications

Esomeprazole is prescribed for gastro-oesophageal reflux disease (GERD), erosive esophagitis, peptic and duodenal ulcers, H. pylori eradication (with antibiotics), Zollinger-Ellison syndrome and NSAID-associated ulcer prophylaxis. Its multiple formats cover oral maintenance, paediatric sachets and injectable hospital use. Prescribers include gastroenterologists, general physicians, surgeons and almost every other specialty.

Why Esomeprazole is a High-Potential Molecule for Distributors

PPIs are among the highest-volume prescription categories in India, driven by widespread acidity, GERD and near-universal co-prescription alongside NSAIDs and antibiotics. Esomeprazole's broad, cross-specialty use and multiple dosage forms make it a foundational, fast-moving SKU family that anchors almost any gastro-focused portfolio. Consistent, high-frequency reorders make it a dependable revenue base for distributors.

Why Choose Cafoli Lifecare

Cafoli Lifecare provides territory-wise monopoly rights, WHO-GMP certified manufacturing, DCGI-approved formulations, complete promotional inputs and the backing of 1000+ franchise partners across India.

References

1. MedlinePlus: Esomeprazole
2. PubChem: Esomeprazole